# Open Label Study Exploring Tissue Histopathology After Ellacor® Procedure in an Abdominoplasty Model.

> **NCT06421207** · NA · COMPLETED · sponsor: **Cytrellis Biosystems, Inc.** · enrollment: 6 (actual)

## Conditions studied

- Histopathology
- Wrinkle
- Rhytides

## Interventions

- **DEVICE:** ellacor® Micro-Coring procedure

## Key facts

- **NCT ID:** NCT06421207
- **Lead sponsor:** Cytrellis Biosystems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-22
- **Primary completion:** 2023-06-19
- **Final completion:** 2023-10-04
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2024-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06421207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06421207, "Open Label Study Exploring Tissue Histopathology After Ellacor® Procedure in an Abdominoplasty Model.". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06421207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*